• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[5-氟尿嘧啶局部治疗阴道HPV相关病变后发生阴道腺病3例]

[Three cases of vaginal adenosis after topical 5-fluorouracil therapy for vaginal HPV-associated lesions].

作者信息

Georgiev D, Karag'ozov I, Velev M, Makaveeva V

出版信息

Akush Ginekol (Sofiia). 2006;45(3):59-61.

PMID:16889191
Abstract

Three cases of vaginal adenosis after topical 5-fluorouracil therapy for vaginal HPV-associated lesions are reported. Three patients with colposcopic, histologic and viral evidences for subclinical papillomavirus infection (in combination with low-grade vaginal intraepithelial neoplasia in of them) are treated with 5-FU. In follow-up control examinations persistent ulcerations were found without regression after applied therapy. By colposcopic and histologic examinations vaginal adenosis was proved without histories of intrautering DES exposure. After the destructive therapy the reported lesions were regressed without appearance of new lesions in follow-up control examinations. The application of 5-fluorouracil has to be used only in cases of recurrent vaginal warts and in cases of high-grade vaginal intraepithelial neoplasia with strict folow-up cytological and colposcopic control examinations.

摘要

报告了3例因阴道HPV相关病变接受局部5-氟尿嘧啶治疗后发生阴道腺病的病例。3例患者经阴道镜、组织学及病毒学检查证实有亚临床乳头瘤病毒感染(其中1例合并低度阴道上皮内瘤变),接受了5-氟尿嘧啶治疗。在随访检查中发现持续溃疡,治疗后未消退。经阴道镜和组织学检查证实为阴道腺病,患者无宫内己烯雌酚暴露史。在采用破坏性治疗后,报告的病变消退,随访检查中未出现新病变。5-氟尿嘧啶仅应用于复发性阴道疣以及高级别阴道上皮内瘤变的病例,并需严格进行细胞学和阴道镜随访检查。

相似文献

1
[Three cases of vaginal adenosis after topical 5-fluorouracil therapy for vaginal HPV-associated lesions].[5-氟尿嘧啶局部治疗阴道HPV相关病变后发生阴道腺病3例]
Akush Ginekol (Sofiia). 2006;45(3):59-61.
2
Topical vidarabine or 5-fluorouracil treatment against persistent HPV in genital (pre)cancerous lesions.
Oncol Rep. 2003 Sep-Oct;10(5):1437-41.
3
Chronic ulcerations following topical therapy with 5-fluorouracil for vaginal human papillomavirus-associated lesions.5-氟尿嘧啶局部治疗阴道人乳头瘤病毒相关病变后出现的慢性溃疡
Obstet Gynecol. 1991 Aug;78(2):205-8.
4
The distribution of low and high-risk HPV types in vulvar and vaginal intraepithelial neoplasia (VIN and VaIN).低风险和高风险人乳头瘤病毒(HPV)类型在外阴和阴道上皮内瘤变(VIN和VaIN)中的分布情况。
Am J Surg Pathol. 2006 Dec;30(12):1513-8. doi: 10.1097/01.pas.0000213291.96401.48.
5
Vaginal columnar cell metaplasia. An acquired adenosis associated with topical 5-fluorouracil therapy.阴道柱状上皮化生。一种与局部5-氟尿嘧啶治疗相关的后天性腺病。
J Reprod Med. 1995 May;40(5):361-6.
6
A randomized, double-blind, placebo-controlled trial of 5-fluorouracil for the treatment of cervicovaginal human papillomavirus.一项关于5-氟尿嘧啶治疗宫颈阴道人乳头瘤病毒的随机、双盲、安慰剂对照试验。
Infect Dis Obstet Gynecol. 1999;7(4):186-9. doi: 10.1002/(SICI)1098-0997(1999)7:4<186::AID-IDOG4>3.0.CO;2-Z.
7
Treatment of vaginal intraepithelial neoplasia with laser and topical 5-fluorouracil.激光联合局部应用5-氟尿嘧啶治疗阴道上皮内瘤变
Obstet Gynecol. 1989 Apr;73(4):657-60.
8
Development of vaginal adenosis following combined 5-fluorouracil and carbon dioxide laser treatments for diffuse vaginal condylomatosis.5-氟尿嘧啶联合二氧化碳激光治疗弥漫性阴道湿疣后阴道腺病的发生
Obstet Gynecol. 1993 May;81(5 ( Pt 2)):896-8.
9
Treatment with 5-fluorouracil of 35 patients with clinical or subclinical HPV infection of the vagina.对35例患有临床或亚临床阴道人乳头瘤病毒感染的患者采用5-氟尿嘧啶进行治疗。
Eur J Gynaecol Oncol. 1996;17(6):534.
10
Intraepithelial vaginal neoplasia following immunosuppressive therapy treated with topical 5-Fu.免疫抑制治疗后发生的上皮内阴道瘤变,采用局部5-氟尿嘧啶治疗。
Obstet Gynecol. 1975 Sep;46(3):360-2.

引用本文的文献

1
An Adsorptive and Antioxidant Vaginal Gel Clears High-Risk HPV- and p16/Ki-67-Associated Abnormal Cytological Cervical Findings: A Subgroup Analysis of a Prospective Randomized Controlled Trial on CIN2 and p16 Positive CIN1.一种具有吸附和抗氧化作用的阴道凝胶清除高危型人乳头瘤病毒及与p16/Ki-67相关的异常宫颈细胞学检查结果:一项关于CIN2和p16阳性CIN1的前瞻性随机对照试验的亚组分析
Front Med (Lausanne). 2021 May 25;8:645559. doi: 10.3389/fmed.2021.645559. eCollection 2021.
2
Primary vaginal clear cell adenocarcinoma accompanied by Herlyn-Werner-Wunderlich syndrome without prenatal diethylstilbestrol exposure: a case report.原发性阴道透明细胞腺癌伴赫林-韦纳-温德利希综合征,无产前己烯雌酚暴露:一例报告
Int J Clin Exp Pathol. 2020 Nov 1;13(11):2784-2787. eCollection 2020.
3
Efficacy and safety of an adsorbent and anti-oxidative vaginal gel on CIN1 and 2, on high-risk HPV, and on p16/Ki-67: a randomized controlled trial.吸附剂和抗氧化阴道凝胶治疗 CIN1 和 2、高危型 HPV 以及 p16/Ki-67 的疗效和安全性:一项随机对照试验。
Arch Gynecol Obstet. 2021 Feb;303(2):501-511. doi: 10.1007/s00404-020-05816-8. Epub 2020 Nov 20.
4
Malignant transformation of vaginal adenosis to clear cell carcinoma without prenatal diethylstilbestrol exposure: a case report and literature review.阴道腺病恶变为透明细胞癌,无产前己烯雌酚暴露:病例报告及文献复习。
BMC Cancer. 2019 Aug 13;19(1):798. doi: 10.1186/s12885-019-6026-1.